Insights

Strategic Partnerships Cardurion Pharmaceuticals has formed foundational partnerships with key strategics and investors, including a significant investment from Bain Capital. Leveraging these strategic relationships can open up sales opportunities for collaborations and business growth.

Expansion Plans Recent news highlights Cardurion's expansion with the hiring of key personnel like Chief Business Officer and Chief People Officer. This expansion signals potential sales opportunities as the company scales up its operations and seeks new avenues for growth and development.

Financial Backing With a Series B funding of $260 million and revenue in the range of $0-10 million, Cardurion Pharmaceuticals demonstrates financial stability and growth potential. Sales development representatives can explore opportunities to offer solutions that align with the company's financial strength and objectives.

Clinical Innovation Cardurion is at the forefront of developing groundbreaking clinical programs in PDE9 and CaMKII inhibition for cardiovascular diseases. Sales professionals can engage with the company by offering innovative solutions that complement their research and development efforts, leading to potential sales collaborations.

Industry Recognition Cardurion Pharmaceuticals has been recognized for its strengths in science, leadership, investors, and strategy by the Endpoints News editorial team. Leveraging this industry recognition can help sales development representatives build credibility and initiate conversations around potential partnership opportunities.

Cardurion Pharmaceuticals Tech Stack

Cardurion Pharmaceuticals uses 8 technology products and services including Open Graph, RSS, jQuery, and more. Explore Cardurion Pharmaceuticals's tech stack below.

  • Open Graph
    Content Management System
  • RSS
    Content Management System
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • Contact Form 7
    Web Platform Extensions
  • MonsterInsights
    Web Platform Extensions
  • Nginx
    Web Servers

Media & News

Cardurion Pharmaceuticals's Email Address Formats

Cardurion Pharmaceuticals uses at least 1 format(s):
Cardurion Pharmaceuticals Email FormatsExamplePercentage
First.Last@cardurion.comJohn.Doe@cardurion.com
50%
First.Last@cardurion.comJohn.Doe@cardurion.com
50%

Frequently Asked Questions

Where is Cardurion Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Cardurion Pharmaceuticals's main headquarters is located at 78 Blanchard Road Suite 200 Burlington, Massachusetts 01803 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Cardurion Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Cardurion Pharmaceuticals's official website is cardurion.com and has social profiles on LinkedIn.

How much revenue does Cardurion Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of June 2025, Cardurion Pharmaceuticals's annual revenue reached $7.5M.

What is Cardurion Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Cardurion Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cardurion Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of June 2025, Cardurion Pharmaceuticals has approximately 75 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: E. R.Chief Medical And Scientific Officer: H. K. S.Chief Operating Officer: M. M.. Explore Cardurion Pharmaceuticals's employee directory with LeadIQ.

What industry does Cardurion Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Cardurion Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Cardurion Pharmaceuticals use?

Minus sign iconPlus sign icon
Cardurion Pharmaceuticals's tech stack includes Open GraphRSSjQueryPHPYoast SEOContact Form 7MonsterInsightsNginx.

What is Cardurion Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Cardurion Pharmaceuticals's email format typically follows the pattern of . Find more Cardurion Pharmaceuticals email formats with LeadIQ.

How much funding has Cardurion Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of June 2025, Cardurion Pharmaceuticals has raised $260M in funding. The last funding round occurred on Jul 16, 2024 for $260M.

When was Cardurion Pharmaceuticals founded?

Minus sign iconPlus sign icon
Cardurion Pharmaceuticals was founded in 2017.
Cardurion Pharmaceuticals

Cardurion Pharmaceuticals

Biotechnology ResearchMassachusetts, United States51-200 Employees

Cardurion Pharmaceuticals is a next generation cardiovascular company focused on the discovery and development of novel therapeutics for the treatment of heart failure and other cardiovascular diseases.  Led by an experienced team of CV experts and industry veterans, we are developing groundbreaking clinical programs in PDE9 and CaMKII inhibition.  We take a strategic portfolio approach driven by in-house drug discovery and our office of strategy and have concluded foundational partnerships with key strategics and investors, including an up to $300 million dollar investment from Bain Capital to support current programs and pipeline growth. Cardurion Pharmaceuticals has facilities in Burlington, Massachusetts and Shonan, Japan. For more information, please visit the company’s website at http://www.cardurion.com.

Section iconCompany Overview

Headquarters
78 Blanchard Road Suite 200 Burlington, Massachusetts 01803 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $260M

    Cardurion Pharmaceuticals has raised a total of $260M of funding over 6 rounds. Their latest funding round was raised on Jul 16, 2024 in the amount of $260M.

  • $10M

    Cardurion Pharmaceuticals's revenue is in the range of $10M

Section iconFunding & Financials

  • $260M

    Cardurion Pharmaceuticals has raised a total of $260M of funding over 6 rounds. Their latest funding round was raised on Jul 16, 2024 in the amount of $260M.

  • $10M

    Cardurion Pharmaceuticals's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.